Geniposide promotes splenic Treg differentiation to alleviate colonic inflammation and intestinal barrier injury in ulcerative colitis mice

References

• Eisenstein M. Ulcerative colitis: towards remission. Nature. 2018;563(7730):S33.
   PubMed Web of Science ®Google Scholar
• Gajendran M, Loganathan P, Jimenez G, et al. A comprehensive review and update on ulcerative colitis(). Dis Mon. 2019;65(12):100851.
   PubMed Web of Science ®Google Scholar
• Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin North Am. 2020;49(4):643–654.
   PubMed Web of Science ®Google Scholar
• Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54 e42. quiz e30.
   PubMed Web of Science ®Google Scholar
• Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis. Lancet. 2017;389(10080):1756–1770.
   PubMed Web of Science ®Google Scholar
• Singh S, Allegretti JR, Siddique SM, et al. AGA technical review on the management of moderate to severe ulcerative colitis. Gastroenterology. 2020;158(5):1465–1496 e1417.
   PubMed Web of Science ®Google Scholar
• Bressler B, Marshall JK, Bernstein CN, et al. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus. Gastroenterology. 2015;148(5):1035–1058 e1033.
   PubMed Web of Science ®Google Scholar
• Feuerstein JD, Cheifetz AS. Ulcerative colitis: epidemiology, diagnosis, and management. Mayo Clin Proc. 2014;89(11):1553–1563.
   PubMed Web of Science ®Google Scholar
• Alsoud D, Verstockt B, Fiocchi C, et al. Breaking the therapeutic ceiling in drug development in ulcerative colitis. Lancet Gastroenterol Hepatol. 2021;6(7):589–595.
   PubMed Web of Science ®Google Scholar
• Hirten RP, Sands BE. New therapeutics for ulcerative colitis. Annu Rev Med. 2021;72(1):199–213.
   PubMedGoogle Scholar
• Naganuma M, Sugimoto S, Mitsuyama K, et al. Efficacy of indigo naturalis in a multicenter randomized controlled trial of patients with ulcerative colitis. Gastroenterology. 2018;154(4):935–947.
   PubMed Web of Science ®Google Scholar
• Cao SY, Ye SJ, Wang WW, et al. Progress in active compounds effective on ulcerative colitis from Chinese medicines. Chin J Nat Med. 2019;17(2):81–102.
   PubMed Web of Science ®Google Scholar
• Ran D, Hong W, Yan W, et al. Properties and molecular mechanisms underlying geniposide-mediated therapeutic effects in chronic inflammatory diseases. J Ethnopharmacol. 2021;273:113958.
   PubMed Web of Science ®Google Scholar
• Li N, Li L, Wu H, et al. Antioxidative property and molecular mechanisms underlying geniposide-mediated therapeutic effects in diabetes mellitus and cardiovascular disease. Oxid Med Cell Longev. 2019;2019:7480512.
   PubMed Web of Science ®Google Scholar
• Xu B, Li YL, Xu M, et al. Geniposide ameliorates TNBS-induced experimental colitis in rats via reducing inflammatory cytokine release and restoring impaired intestinal barrier function. Acta Pharmacol Sin. 2017;38(5):688–698.
   PubMed Web of Science ®Google Scholar
• Lu Y, Chen J, He X, et al. Combined administration of vitamin D3 and geniposide is less effective than single use of vitamin D3 or geniposide in the treatment of ulcerative colitis. Front Pharmacol. 2021;12:714065.
   PubMed Web of Science ®Google Scholar
• Yang H, Yue Y, Li Y, et al. Geniposide attenuates dextran sulfate sodium-induced colitis in mice via Nrf-2/HO-1/NF-kappaB pathway. Ann Palliat Med. 2020;9(5):2826–2836.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li Y, Shen P, et al. Administration of geniposide ameliorates dextran sulfate sodium-induced colitis in mice via inhibition of inflammation and mucosal damage. Int Immunopharmacol. 2017;49:168–177.
   PubMed Web of Science ®Google Scholar
• Pu Z, Liu Y, Li C, et al. Using network pharmacology for systematic understanding of geniposide in ameliorating inflammatory responses in colitis through suppression of NLRP3 inflammasome in macrophage by AMPK/Sirt1 dependent signaling. Am J Chin Med. 2020;48(7):1693–1713.
   PubMed Web of Science ®Google Scholar
• Hindryckx P, Jairath V, D’Haens G. Acute severe ulcerative colitis: from pathophysiology to clinical management. Nat Rev Gastroenterol Hepatol. 2016;13(11):654–664.
   PubMed Web of Science ®Google Scholar
• Neurath MF. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nat Immunol. 2019;20(8):970–979.
   PubMed Web of Science ®Google Scholar
• Chen G, Ran X, Li B, et al. Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine. 2018;30:317–325.
   PubMed Web of Science ®Google Scholar
• Lian P, Braber S, Varasteh S, et al. Hypoxia and heat stress affect epithelial integrity in a Caco-2/HT-29 co-culture. Sci Rep. 2021;11(1):13186.
   PubMed Web of Science ®Google Scholar
• Meng Q, Li Y, Ji T, et al. Estrogen prevent atherosclerosis by attenuating endothelial cell pyroptosis via activation of estrogen receptor alpha-mediated autophagy. J Adv Res. 2021;28:149–164.
   PubMed Web of Science ®Google Scholar
• Zhang H, Yuan Z, Zhu Y, et al. Th17/Treg imbalance mediates hepatic intolerance to exogenous lipopolysaccharide and exacerbates liver injury in triptolide induced excessive immune response. J Ethnopharmacol. 2022;295:115422.
   PubMed Web of Science ®Google Scholar
• Meng Q, Yu X, Chen Q, et al. Liuwei Dihuang soft capsules inhibits the phenotypic conversion of VSMC to prevent the menopausal atherosclerosis by up-regulating the expression of myocardin. J Ethnopharmacol. 2020;246:112207.
   PubMed Web of Science ®Google Scholar
• Meng Q, Li J, Chao Y, et al. beta-estradiol adjusts intestinal function via ERbeta and GPR30 mediated PI3K/AKT signaling activation to alleviate postmenopausal dyslipidemia. Biochem Pharmacol. 2020;180:114134.
   PubMed Web of Science ®Google Scholar
• Luz-Crawford P, Kurte M, Bravo-Alegria J, et al. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther. 2013;4(3):65.
   PubMedGoogle Scholar
• Miao Y, Zheng Y, Geng Y, et al. The role of GLS1-mediated glutaminolysis/2-HG/H3K4me3 and GSH/ROS signals in Th17 responses counteracted by PPARgamma agonists. Theranostics. 2021;11(9):4531–4548.
   PubMed Web of Science ®Google Scholar
• Conrad K, Roggenbuck D, Laass MW. Diagnosis and classification of ulcerative colitis. Autoimmun Rev. 2014;13(4–5):463–466.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Siegmund B, Le Berre C, et al. Ulcerative colitis. Nat Rev Dis Primers. 2020;6(1):74.
   PubMed Web of Science ®Google Scholar
• Zhou YX, Zhang RQ, Rahman K, et al. Diverse pharmacological activities and potential medicinal benefits of geniposide. Evid Based Complement Alternat Med. 2019;2019:4925682.
   PubMed Web of Science ®Google Scholar
• Balestrieri P, Ribolsi M, Guarino MPL, et al. Nutritional aspects in inflammatory bowel diseases. Nutrients. 2020;12(2):372.
   PubMed Web of Science ®Google Scholar
• Mizukawa K, Takayama H, Sato H, et al. Alterations of muscarinic cholinergic receptors in the hippocampal formation of stressed rat: in vitro quantitative autoradiographic analysis. Brain Res. 1989;478(1):187–192.
   PubMed Web of Science ®Google Scholar
• Cabre E, Gassull MA. Nutrition in inflammatory bowel disease: impact on disease and therapy. Curr Opin Gastroenterol. 2001;17(4):342–349.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang K, Liu J, et al. Geniposide suppresses thermogenesis via regulating PKA catalytic subunit in adipocytes. Toxicology. 2021;464:153014.
   PubMed Web of Science ®Google Scholar
• Michielan A, D’Inca R. Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Mediators Inflamm. 2015;2015:628157.
   PubMed Web of Science ®Google Scholar
• Buckley A, Turner JR. Cell biology of tight junction barrier regulation and mucosal disease. Cold Spring Harb Perspect Biol. 2018;10(1):a029314.
   PubMed Web of Science ®Google Scholar
• Gunzel D, Fromm M. Claudins and other tight junction proteins. Compr Physiol. 2012;2(3):1819–1852.
   PubMed Web of Science ®Google Scholar
• Gunzel D, Yu AS. Claudins and the modulation of tight junction permeability. Physiol Rev. 2013;93(2):525–569.
   PubMed Web of Science ®Google Scholar
• Otani T, Furuse M. Tight junction structure and function revisited. Trends Cell Biol. 2020;30(10):805–817.
   PubMed Web of Science ®Google Scholar
• SharmaD, Malik A, Guy CS, et al. Pyrin inflammasome regulates tight junction integrity to restrict colitis and tumorigenesis. Gastroenterology. 2018;154(4):948–964 e948.
   PubMed Web of Science ®Google Scholar
• Steinbach EC, Plevy SE. The role of macrophages and dendritic cells in the initiation of inflammation in IBD. Inflamm Bowel Dis. 2014;20(1):166–175.
   PubMed Web of Science ®Google Scholar
• Saraiva M, Vieira P, O’Garra A. Biology and therapeutic potential of interleukin-10. J Exp Med. 2020;217(1). DOI:10.1084/jem.20190418
   PubMed Web of Science ®Google Scholar
• Geng Y, Yue Y, Guan Q, et al. Cereal vinegar sediment alleviates spontaneous ulcerative colitis in Il-10 deficient mice. Mol Nutr Food Res. 2021;65(24):e2001227.
   PubMed Web of Science ®Google Scholar
• Murphy SF, Rhee L, Grimm WA, et al. Intestinal epithelial expression of TNFAIP3 results in microbial invasion of the inner mucus layer and induces colitis in IL-10-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2014;307(9):G871–882.
   PubMed Web of Science ®Google Scholar
• Chen XY, Jiang WW, Liu YL, et al. Anti-inflammatory action of geniposide promotes wound healing in diabetic rats. Pharm Biol. 2022;60(1):294–299.
   PubMed Web of Science ®Google Scholar
• Yao Y, Simard AR, Shi FD, et al. IL-10-producing lymphocytes in inflammatory disease. Int Rev Immunol. 2013;32(3):324–336.
   PubMed Web of Science ®Google Scholar
• Melgar S, Yeung MM, Bas A, et al. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol. 2003;134(1):127–137.
   PubMed Web of Science ®Google Scholar
• Geremia A, Biancheri P, Allan P, et al. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev. 2014;13(1):3–10.
   PubMed Web of Science ®Google Scholar
• Corridoni D, Antanaviciute A, Gupta T, et al. Single-cell atlas of colonic CD8(+) T cells in ulcerative colitis. Nat Med. 2020;26(9):1480–1490.
   PubMed Web of Science ®Google Scholar
• Cook L, Stahl M, Han X, et al. Suppressive and gut-reparative functions of human type 1 T regulatory cells. Gastroenterology. 2019;157(6):1584–1598.
   PubMed Web of Science ®Google Scholar
• Schmitt H, Ulmschneider J, Billmeier U, et al. The TLR9 AGONIST COBITOLIMOD INDUCES IL10-producing wound healing macrophages and regulatory T cells in ulcerative colitis. J Crohns Colitis. 2020;14(4):508–524.
   PubMed Web of Science ®Google Scholar
• Rosenzwajg M, Lorenzon R, Cacoub P, et al. Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial. Ann Rheum Dis. 2019;78(2):209–217.
   PubMed Web of Science ®Google Scholar
• Liao P, Liu L, Wang B, et al. Baicalin and geniposide attenuate atherosclerosis involving lipids regulation and immunoregulation in ApoE-/- mice. Eur J Pharmacol. 2014;740:488–495.
   PubMed Web of Science ®Google Scholar
• Deng G, Song X, Fujimoto S, et al. Foxp3 post-translational modifications and treg suppressive activity. Front Immunol. 2019;10:2486.
   PubMed Web of Science ®Google Scholar
• Long Y, Wang C, Xia C, et al. Recovery of CD226-TIGIT(+)FoxP3(+) and CD226-TIGIT-FoxP3(+) regulatory T cells contributes to clinical remission from active stage in ulcerative colitis patients. Immunol Lett. 2020;218:30–39.
   PubMed Web of Science ®Google Scholar